Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: There is a paucity of knowledge regarding NEN and HIV infection in the literature.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Hayes A, Smith K, Liu M, Jenkinson S, Grossman A,
Keywords: Neuroendocrine, Carcinoid, Merkel cell carcinoma, Human immunodeficiency virus, HIV, Prognosis,
Introduction: The incidence of bone metastases (BM) in patients with NENs is 12-25%, and skeletal related events (SREs) occur in up to 21% of affected cases. Data about the efficacy of bisphosphonates in NEN patients (pts) with BM are limited.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Armeni E, Hayes A, Gopaul A, Aristidou I, Navalkissoor S,
Keywords: bone metastases, NEN, zoledronic acid, skeletal related event,
Introduction: DIPNECH is considered a rare condition and the natural history is poorly described. It is thought to give rise to pulmonary carcinoids (PCs) (>5mm) or tumourlets (≤5mm).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Hayes A
Authors: Hayes A, Banks J, Shah H, Luong T, Navalkissoor S,
Keywords: dipnech, diffuse idiopathic neuroendocrine cell hyperplasia, tumourlet, carcinoid, neuroendocrine tumor, multiple pulmonary nodules,
Introduction: The antiproliferative properties of LA in GEP NETs were demonstrated in the recently published CLARINET study
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Laskaratos F, Megapanou M, Papantoniou D, Hayes A, von Stempel C,
Keywords: lanreotide, neuroendocrine tumor,
Introduction: LuTate is a treatment for well-differentiated NETs with adequate somatostatin receptor expression. Prognostic biomarkers in this population are lacking. Neutrophil-to-lymphocyte ratio (NLR) is prognostic in the majority of solid tumours but is reported to have less value in indolent well-differentiated NETs.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Hayes A, Hosking E, Thomas D, Sjoquist K, Chan D,
Keywords: prognostic, biomarker, PRRT, LuTate,